{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:47:37Z","timestamp":1793292457047,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cgh.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:39:19Z","timestamp":1562931559000},"page":"2416-2422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review"],"prefix":"10.1016","volume":"17","author":[{"given":"Christopher L.","family":"Bowlus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.07.011_bib1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.07.011_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib4","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/lt.22161","article-title":"Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations","volume":"16","author":"Bowlus","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2019.07.011_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cgh.2017.10.028","article-title":"Primary sclerosing cholangitis is not rare among blacks in a multicenter North American consortium","volume":"16","author":"Goldberg","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.07.011_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.07.011_bib8","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cgh.2016.11.025","article-title":"Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis","volume":"15","author":"Fumery","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib11","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a pre-malignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib13","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.07.011_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib16","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13193-011-0042-1","article-title":"Serum CA 19-9 as a biomarker for pancreatic cancer-a comprehensive review","volume":"2","author":"Ballehaninna","year":"2011","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.cgh.2019.07.011_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2004-828891","article-title":"Serum and bile markers for cholangiocarcinoma","volume":"24","author":"Nehls","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2019.07.011_bib21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2019.07.011_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib23","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.21873\/anticanres.12931","article-title":"Relationship between CA 19.9 and the Lewis phenotype: options to improve diagnostic efficiency","volume":"38","author":"Parra-Robert","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cgh.2019.07.011_bib24","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","article-title":"FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"59","author":"Wannhoff","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ajg.2014.433","article-title":"Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis","volume":"110","author":"Eaton","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.gie.2013.11.001","article-title":"Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Navaneethan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2019.07.011_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11901-017-0341-2","article-title":"Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?","volume":"16","author":"Chapman","year":"2017","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.cgh.2019.07.011_bib31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2014.07.032","article-title":"Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET","volume":"61","author":"Sangfelt","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib32","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2019.07.011_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncy.21303","article-title":"Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success","volume":"121","author":"Kipp","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cgh.2019.07.011_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/cncy.21509","article-title":"Strategies for improving diagnostic accuracy of biliary strictures","volume":"123","author":"Salomao","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cgh.2019.07.011_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrgastro.2015.182","article-title":"Evaluation of indeterminate biliary strictures","volume":"13","author":"Bowlus","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib36","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v19.i43.7661","article-title":"Diagnosis of IgG4-related sclerosing cholangitis","volume":"19","author":"Nakazawa","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib37","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1055\/s-0034-1391845","article-title":"Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis","volume":"47","author":"Arnelo","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2019.07.011_bib38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3109\/00365521.2014.936032","article-title":"Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis","volume":"49","author":"Kalaitzakis","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib39","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.07.011_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-198801000-00005","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis","volume":"207","author":"Marsh","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2019.07.011_bib41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gut.32.11.1369","article-title":"Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation","volume":"32","author":"Miros","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2019.07.011_bib42","first-page":"410","article-title":"[Liver transplantation in patients with primary sclerosing cholangitis. Determining timing with reference to risk of malignancy]","volume":"113","author":"Nashan","year":"1996","journal-title":"Langenbecks Arch Chir Suppl Kongressbd"},{"key":"10.1016\/j.cgh.2019.07.011_bib43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib44","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2019.07.011_bib45","doi-asserted-by":"crossref","first-page":"S1097","DOI":"10.1016\/S0016-5085(18)33654-0","article-title":"Gallbladder polyps in patients with primary sclerosing cholangitis; frequency, risk factors and outcome","volume":"154","author":"Sagvand","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.07.011_bib46","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S0618-8278(19)30140-9","article-title":"Risk of gall bladder cancer in patients with primary sclerosing cholangitis and gall bladder polyps: an opportunity to revisit the guidelines","volume":"70","author":"van Erp","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib47","first-page":"CD012233","article-title":"Transabdominal ultrasound and endoscopic ultrasound for diagnosis of gallbladder polyps","volume":"8","author":"Wennmacker","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2019.07.011_bib48","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3748\/wjg.v10.i8.1204","article-title":"CT biliary cystoscopy of gallbladder polyps","volume":"10","author":"Lou","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2019.07.011_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.07.011_bib52","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.07.011_bib53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2019.07.011_bib54","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.07.011_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651930744X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651930744X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:30:28Z","timestamp":1761543028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651930744X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S154235651930744X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}